KLOW (KL80) is a sophisticated multi-peptide complex formulation designed for advanced biochemical research, representing a carefully calibrated combination of four distinct bioactive peptide sequences that work synergistically to provide a versatile tool for investigators studying cellular signaling, tissue response mechanisms, and extracellular matrix dynamics. This product, identified by model designation KL80 and commonly referred to as KLOW, is supplied as a sterile lyophilized white to off-white powder or loose block, with a total peptide content of 80mg per vial, precisely apportioned into four individual components including 50mg of GHK-Cu, 10mg of a 15-amino acid peptide derived from a protective gastric protein, 10mg of a 43-amino acid synthetic peptide analog, and 10mg of KPV, each synthesized using solid-phase peptide synthesis (SPPS) methodologies followed by rigorous high-performance liquid chromatography (HPLC) purification to achieve purity levels consistently exceeding 98%, with two of the components specifically verified at ≥99% purity through comprehensive quality control protocols including mass spectrometry (MS) and amino acid analysis (AAA). The KL80 complex is distinguished by its rational peptide selection, where GHK-Cu functions as a copper-bound tripeptide that has been extensively characterized in laboratory models for its role in modulating metal-dependent enzymatic activities and supporting extracellular matrix remodeling, while the 15-amino acid gastric protein-derived peptide has demonstrated remarkable stability in aqueous solutions and exhibits properties that support cellular migration and the maintenance of barrier integrity in various in vitro systems. The inclusion of the 43-amino acid synthetic peptide analog provides researchers with a tool to investigate actin polymerization dynamics, cell spreading, and cytoskeletal reorganization, as this peptide is known to sequester G-actin and modulate the availability of monomeric actin for filament assembly, thereby influencing numerous cellular processes that depend on dynamic cytoskeletal rearrangements. Completing the quartet is KPV, a tripeptide corresponding to the C-terminal fragment of alpha-melanocyte stimulating hormone (alpha-MSH), which has been the subject of numerous studies examining its properties in controlled experimental models of cellular stress and its interactions with melanocortin receptor signaling pathways, though the precise mechanisms continue to be elucidated by the research community. The lyophilized powder format of KL80 has been deliberately selected to preserve the structural integrity and bioactivity of each constituent peptide during extended storage and transportation, with the white to off-white appearance serving as a visual indicator of successful lyophilization cycles that remove residual moisture without compromising peptide backbone or side-chain functionalities. Upon reconstitution in appropriate sterile aqueous buffers or deionized water, the powder rapidly dissolves to yield a clear to slightly hazy solution depending on the ionic strength and pH of the diluent, with optimal solubility observed in slightly acidic to neutral pH buffers typically ranging from 4.0 to 7.0, and researchers are strongly advised to centrifuge the vial briefly before opening to ensure any loose powder collects at the bottom of the container, thereby minimizing electrostatic loss of the fine solid material during handling. Each vial of KL80 is clearly labeled with the product name, model number KL80, the designation KLOW, net peptide weight (80mg total with individual component breakdown), purity percentages for each constituent peptide, batch-specific lot number, recommended storage conditions requiring desiccated freezing at minus twenty degrees Celsius or lower, and corresponding reference identifiers for each component, facilitating comprehensive traceability and inventory management in regulated laboratory environments. The molecular weights of the individual components have been precisely calculated from their respective amino acid compositions, with GHK-Cu at approximately 403.9 Daltons, the gastric protein-derived 15-amino acid peptide at approximately 1419.6 Daltons, the 43-amino acid synthetic analog at approximately 4963.5 Daltons, and KPV at approximately 402.5 Daltons, and researchers are encouraged to verify these values upon receipt using their own mass spectrometry protocols as part of standard quality assurance procedures. Under the recommended storage conditions of desiccated freezing at -20°C or -80°C, the lyophilized KL80 complex remains stable for twelve to eighteen months without detectable degradation as verified by accelerated stability studies employing HPLC and mass spectrometry, though after reconstitution, the peptide solution should be immediately aliquoted into single-use volumes and stored frozen, avoiding repeated freeze-thaw cycles which may accelerate aggregation, deamidation, or other degradation pathways that could compromise experimental reproducibility. Each production batch of KL80 undergoes comprehensive quality control testing that includes peptide content determination, net peptide weight analysis, bacterial endotoxin screening to ensure compliance with standard biochemical purity requirements, and sterility testing where appropriate for research-grade materials, with detailed Certificates of Analysis (CoA) readily available to customers upon request, providing full transparency regarding purity levels, HPLC chromatograms, mass spectrometry verification data, and stability study summaries. The KL80 multi-peptide complex is synthesized in state-of-the-art GMP-compliant facilities using automated peptide synthesizers to ensure batch-to-batch consistency, followed by HPLC purification that achieves main peak purity exceeding the nominal 98% threshold for all four components, with related substance profiles indicating the absence of significant deletion or truncation sequences that could otherwise introduce confounding variables into sensitive biochemical assays. The structural authenticity of each peptide component is routinely verified by amino acid analysis (AAA) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, providing unequivocal confirmation of the correct molecular identity for each component, and reverse-phase HPLC chromatograms generated for each production batch demonstrate sharp, symmetric main peaks with consistent retention times relative to reference standards, confirming proper folding and the absence of significant oxidized or otherwise modified species. The product is supplied in amber glass vials with fluoropolymer-coated stoppers to minimize adventitious adsorption of the peptide to container surfaces and to prevent leaching of plasticizers that could interfere with sensitive biological assays, and the vials are sealed under controlled atmospheric conditions to exclude moisture and oxygen, both of which are known to promote peptide degradation over extended storage periods. For research applications involving cell culture models, the KL80 complex is typically reconstituted in sterile deionized water or a compatible physiological buffer system such as phosphate-buffered saline (PBS) or acetate buffer, and due to the differing solubility characteristics of the four components, it is recommended to reconstitute the entire vial contents simultaneously to maintain the intended 50:10:10:10 ratio of GHK-Cu to the gastric protein-derived peptide to the synthetic analog to KPV, rather than attempting to weigh out sub-aliquots from the lyophilized powder, which may not be homogeneously mixed despite extensive blending during manufacturing. When used in combination with cell culture models of metabolic or oxidative stress, the KL80 multi-peptide complex demonstrates reproducible dose-response characteristics, with effective concentrations typically ranging from low nanomolar to low micromolar depending on the specific cell type, endpoint measured, and whether the components are being studied collectively or individually, though investigators are advised to perform their own dose-ranging studies to optimize conditions for their particular experimental system. The KL80 complex provides significant practical advantages over purchasing individual peptides separately and mixing them manually in the laboratory, as each component has been synthesized, purified, and lyophilized in a single integrated production process, eliminating batch-to-batch variability that could arise from sourcing different peptides from different suppliers at different times, and the single-vial format simplifies inventory management and reduces the risk of pipetting errors or contamination during the preparation of custom mixtures. This product is intended exclusively for trained professionals in biochemical and cell biology laboratories who require highly characterized peptides for controlled in vitro or ex vivo experimental systems, and while the individual components have been studied extensively in published literature for their various biological properties, the KL80 complex itself represents a research tool that enables investigators to explore potential synergistic interactions among these well-documented peptide sequences. For quality control purposes, each unit of KL80 is accompanied by a comprehensive certificate of analysis detailing the specific purity percentages for each of the four components (GHK-Cu, the gastric protein-derived 15-amino acid peptide, the 43-amino acid synthetic analog, and KPV), net peptide content expressed both as total milligrams and as milligrams per component, solubility profile data, residual moisture content, endotoxin units per milligram, and storage recommendations, all of which support systematic and reproducible scientific investigation. The small molecular sizes of the constituent peptides, ranging from the tripeptides GHK-Cu and KPV at approximately 400 Daltons up to the 43-amino acid synthetic analog at approximately 5000 Daltons, allow for rapid diffusion in tissue culture media and efficient penetration of extracellular spaces, enabling investigators to achieve consistent molar concentrations with minimal precipitation issues when working within the recommended concentration ranges. Storage of unopened lyophilized vials at controlled room temperature for short intervals during active use, such as for a few days while an experiment is in progress, is acceptable provided the vials remain tightly sealed and protected from humidity, but long-term preservation beyond one month requires the stability provided by continuous freezer storage at -20°C or lower, and researchers should never store reconstituted peptide solutions at refrigerator temperatures for extended periods as degradation rates increase significantly in liquid compared to lyophilized formats. Finally, KLOW (KL80) is distributed as a high-purity biochemical reagent intended to support fundamental research into cellular signaling, tissue maintenance mechanisms, extracellular matrix biology, and the complex interplay between different bioactive peptide signaling molecules, and each batch is accompanied by complete documentation to support the high standards of reproducibility and transparency that modern scientific investigation demands.
Malaysia
United States
Netherlands
United Kingdom
Canada
Australia
Latvia
Israel
Hungary
India
Germany
